KEYNOTE SPEAKER BIOGRAPHIES
Dr Jervoise Andreyev, MRCP PhD
Chelsea & Westminster Hospital, London
Dr Jervoise Andreyev read Arabic at Cambridge and then worked in the City before switching to medicine.
He was student at the London Hospital in Whitechapel, and completed his PhD at the Institute of Cancer
Research. His registrar training was at St Mark’s and then in West London.
In 2000, he was appointed senior lecturer at Imperial and consultant gastroenterologist at the Chelsea and
Westminster Hospital. In 2006, he was appointed Consultant Gastroenterologist in Pelvic Radiation Disease
at the Royal Marsden Hospital.
He runs an active research group with a particular interest in the prevention of radiotherapy induced bowel
injury and development of new treatments. He is probably the only gastroenterologist worldwide appointed
to treat patients with radiation injury and remains baffled as to why the fascinating gastrointestinal problems
of patients cured of their cancer but left with often desperately debilitating symptoms receives such short
shrift from oncologists and gastroenterologists alike. Progressive small vessel ischaemia and subsequent
fibrosis within the gastrointestinal tract is the cause for most radiation-induced symptoms and has much to
teach us about disease processes in other gastrointestinal conditions.
Dr Stephen B Hanauer, MD
The University of Chicago Medical Center in Chicago, Illinois, USA
Dr Hanauer is Professor of Medicine and Clinical Pharmacology and Director of the Section of
Gastroenterology, Hepatology and Nutrition at The University of Chicago Medical Center in Chicago,
Illinois. He is also Director of the Logan Center for Gastrointestinal Research and Co-Director of the
Inflammatory Bowel Disease Research Center at The University of Chicago. Dr Hanauer received his
bachelor’s degree from the University of Michigan in Ann Arbor, Michigan, and his doctorate of medicine,
with honors, from the University of Illinois in Chicago. He completed his internship and residency in
internal medicine, as well as his fellowship in gastroenterology, at The University of Chicago. Dr Hanauer
is board certified in internal medicine and gastroenterology by the American Board of Internal Medicine
and the American Board of Gastroenterology, respectively.
In connection with the American Gastroenterological Association, he served as chair for the Inflammation,
Immunology, and Inflammatory Bowel Disease Section, subsequently also serving as Councilor for Clinical
Research on the governing board and as chair of the Clinical Practice Section. He is the recipient of both
the AGA/Miles and Shirley Fiterman Foundation Clinical Research in Gastroenterology Award and the
Janssen Award for Clinical Excellence.
Dr Hanauer has authored or co-authored hundreds of peer-reviewed journal articles, books and book
chapters, abstracts, monographs, and editorials. He also designed and maintains a 6,000-patient database for
the Inflammatory Bowel Disease Registry. Dr Hanauer is Editor-in-Chief of Nature Clinical Practice
Gastroenterology & Hepatology and serves on the editorial boards of numerous journals, including the
American Journal of Gastroenterology, the American Journal of Medicine, and Inflammatory Bowel
Diseases. He is the outgoing chairman of the International Organization for Inflammatory Bowel Disease.
1
Dr Christopher J Hawkey
Nottingham University
Dr Christopher Hawkey is Professor of Gastroenterology at Nottingham University and Co-director of
Nottingham University’s Institute of Clinical Research, and President Elect of the British Society of
Gastroenterology 2009.
He was educated in Oxford and trained at the Middlesex Hospital, London. He has worked at The Central
Middlesex Hospital, Northwick Park Hospital, and Brompton Hospital (all in London), the Radcliffe
Infirmary, Oxford, and the Queen’s Medical Centre, Nottingham.
Dr Hawkey’s research interests include peptic ulcer disease caused by NSAIDs and Helicobacter pylori and
inflammation bowel disease. As Co-director of the Institute of Clinical Research, he encourages research
collaborations, especially those that capitalise upon Nottingham’s particular skills in clinical trials
organisation, epidemiology with large databases and translational and integrative human research.
Professor Glyn G Jamieson
University of Adelaide, Australia
Professor Jamieson graduated in Medicine at the University of Adelaide in 1966, and obtained his
Australasian Fellowship in the College of Surgeons in 1971. He then undertook further training in the
United Kingdom at the Norfolk and Norwich Hospitals in 1971, and at the Royal Infirmary, Edinburgh in
1972. Following this, he continued his surgical training in the United States of America at the University of
Rochester in 1973, and Duke University in 1974.
He returned to Adelaide as Senior Lecturer in the Department of Surgery in 1975 and was appointed to the
Dorothy Mortlock Chair in Surgery at the University of Adelaide in 1982, which position he has held to the
present.
His clinical and research interest are concentrated in the area of upper gastrointestinal surgery, with specific
interests in upper gastrointestinal motility and surgery of the oesophagus.
He is married with four children and has outside interests in music, wine and old English glass (collects the
glass to drink the wine while listening to the music). He has a small farm, on which he developed a
vineyard, and has undertaken a degree in winemaking.
Dr Gerald T Keusch
Boston University, USA
Dr Gerald T Keusch is a graduate of Columbia University and Harvard Medical School, and trained in
internal medicine and infectious diseases. His academic career has focused on the pathogenesis of intestinal
infections, and he is the author of over 300 publications.
He is currently Associate Provost for Global Health and Director of the Global Health Initiative at Boston
University. Prior to this appointment he was Associate Director for International Research and Director of
the Fogarty International Center at the US National Institutes of Health.
2
Professor Günter Klöppel
University of Kiel, Germany
Günter Klöppel was born on 22 April 1943 in Darmstadt, Germany. He graduated from the Medical School
of the University of Hamburg in 1967. From 1970 to 1987 he worked at the Department of Pathology,
University of Hamburg, where he trained and specialized in pathology, became a docent and finally an
associate professor.
From 1987 until 1995 he led the Department of Pathology of the Academic Hospital Jette, Free University
of Brussels. Since September he has been Head of the Department of Pathology of the University of Kiel,
Germany. Currently he is chairman of the Center of Clinicotheoretical Departments of the SchleswigHolstein University Hospitals, Campus Kiel.
Professor Klöppel was Secretary (1992-98) and later President (2001-02) of the German Society of
Pathology. He was President of the Endocrine Pathology Society (1999-2000) and President of the
European Society of Pathology (ESP). Currently he is chairman of the Advisory Board of the ESP. He is
Honorary Member of the Spanish Society of Pathology and the Belgian Society of Gastroenterology.
His principal research interests are in the tumor biology and pathology of the gastroenteropancreatic
neuroendocrine system and the exocrine pancreas.
Mr. Roger J Leicester OBE MB FRCS
St. George’s Hospital, London
Roger Leicester is currently Director of Endoscopy Services and the SW London Bowel Cancer Screening
Centre at St. George’s Hospital, London. Having graduated from St. Mary’s Hospital, London in 1971 he
underwent his surgical training in the Royal Navy, Basingstoke and St. Mark’s, resigning his post as
Professor of Surgery to move to St. George’s in 1991.
He has served on BSG Council and as a member of the Endoscopy committee and was Secretary of the
BSG from 1985-1989; following which he chaired the Audit Committee for 11 years and was instrumental
in setting up JAG. During his tenure on the Audit Committee, he coordinated three major regional
endoscopy audits, OGD, Colonoscopy and Acute Upper GI bleeding.
Armed with the evidence from the audits, he pursued his goal of improving endoscopy standards by
resigning half of his NHS sessions to set up a national endoscopy training programme via the Education
Department at the Royal College of Surgeons, funded by charity and industry. This laid the foundation for
the National Endoscopy Training Programme which is now a mandatory part of training all endoscopists. In
addition to the UK, he has set up endoscopy and endoscopy nurse training programmes in the Middle and
Far East and has worked through OMGE and OMED to improve standards and training throughout the
world.
He has produced over 50 publications and 200 presentations ranging from combat surgery and design of
hospital ships to colorectal disease and endoscopy. His current research programme is directed towards
identifying genetic risk factors for colorectal cancer and chemoprevention, using natural products.
3
Professor Chris Mulder
University Medical Center, Amsterdam, Netherlands
Professor Chris Mulder is currently working as a Gastroenterologist at the University Medical Center,
Amsterdam. Chris started his career studying medicine and from 1983 he worked as an internist in the area
of hematology under Professor Dr Veltkamp in Leiden until 1984. He moved on changing his focus on
Gastroenterology with Prof. Dr. Tytgat, AMC Amsterdam and from 1989 to 2003 he worked as a
gastroenterologist at the Ziekenhuis Rijnstate in Arnheim before he moved to Amsterdam.
Professor Mulder has an honorary professorship GE at “Universitas Iulia Hatieganu” Cluj-Napoca and is an
honorary member of the South African Gastroenterology Society. Furthermore he belongs to several other
scientific societies.
R. Balfour Sartor, MD
Midgette Distinguished Professor of Medicine, Microbiology and Immunology
University of North Carolina-Chapel Hill, USA
Dr Sartor graduated from Washington & Lee University, Lexington, Virginia and Baylor College of
Medicine, Houston, Texas with honors and completed his Internal Medicine residency at Baylor and
Gastroenterology fellowship at the University of North Carolina. He has been a faculty member at UNC
since fellowship, where he is now the Midgette Distinguished Professor of Medicine, Microbiology and
Immunology and Co-Chief (Research) of the Gastroenterology and Hepatology Division, Director of the
Multidisciplinary IBD Center and Director of the National Gnotobiotic Rodent Resource Center.
Dr Sartor studies the pathogenesis of Crohn’s disease and ulcerative colitis and translating this basic science
knowledge into improved diagnosis and treatment. His basic research investigates the role of commensal
intestinal bacteria in the induction, perpetuation, prevention and treatment of immune-mediated intestinal
inflammation. He has demonstrated that commensal bacteria are essential for chronic, immune-mediated
intestinal inflammation in a bacterial and host-specific manner. His clinical research investigates
antibiotics, probiotics and prebiotics in IBD.
Dr Sartor has been one of the Best Doctors in America for the past 9 years. He has published over 250
peer-reviewed research articles, reviews, editorials and chapters and has edited 5 books, including Kirsner’s
Inflammatory Bowel Diseases, 6th edition with Bill Sandborn.
Professor Nicholas J. Talley, MD, PhD
Mayo Clinic in Jacksonville, Florida, USA
Nick Talley, MD, PhD, is the Chair of the Department of Internal Medicine at the Mayo Clinic in
Jacksonville, Florida. He holds the rank of Professor of Medicine at the Mayo Clinic College of Medicine.
He also holds the rank of Professor of Epidemiology. Dr. Talley has joint appointments in the Divisions of
Gastroenterology & Hepatology and Epidemiology in Mayo Clinic Rochester and Mayo Clinic
Jacksonville. He was formerly Director of the Motility Interest Group in the Division of Gastroenterology
& Hepatology at Mayo Clinic, Rochester, Minnesota, and before that was the Foundation Professor of
Medicine, Nepean Hospital and the University of Sydney.
Dr Talley is currently editor-in-chief of the American Journal of Gastroenterology and serves on a number
of prominent editorial boards. He is a founding member of the Rome Foundation, a past President of the
4
Functional Brain-Gut Research Group, was a counselor in the American Gastroenterology Association
Motility Section, and serves as a member of the Board of the American College of Gastroenterology.
Dr Talley has a major interest in medical education. His popular student textbook, “Clinical Examination: A
Systematic Guide to Physical Diagnosis”, is in its 5th edition and is distributed worldwide.
Dr Talley’s research is primarily focused on functional disorders, dyspepsia, gastroesophageal reflux
disease, Helicobacter pylori and eosinophilic disorders of the gut. He has recently described with his team
the description of a new disease entity, eosinophilic duodenitis, linked to functional dyspepsia. His group
has also documented a genetic component in upper and lower functional bowel diseases. He has published
over 500 original and review articles in the peer-reviewed literature, and he is considered one of the leading
authorities in clinical research on the stomach. He currently has support from the NIH as Principal
Investigator evaluating the pathophysiology and pharmacogenomics of antidepressant therapy in functional
dyspepsia.
Professor R. Balfour Sartor, M.D.
Midgette Distinguished Professor of Medicine, Microbiology and Immunology
University of North Carolina-Chapel Hill, USA
Dr Sartor graduated from Washington & Lee University, Lexington, Virginia and Baylor College of
Medicine, Houston, Texas with honors and completed his Internal Medicine residency at Baylor and
Gastroenterology fellowship at the University of North Carolina. He has been a faculty member at UNC
since fellowship, where he is now the Midgette Distinguished Professor of Medicine, Microbiology and
Immunology and Co-Chief (Research) of the Gastroenterology and Hepatology Division, Director of the
Multidisciplinary IBD Center and Director of the National Gnotobiotic Rodent Resource Center.
Dr Sartor studies the pathogenesis of Crohn’s disease and ulcerative colitis and translating this basic science
knowledge into improved diagnosis and treatment. His basic research investigates the role of commensal
intestinal bacteria in the induction, perpetuation, prevention and treatment of immune-mediated intestinal
inflammation. He has demonstrated that commensal bacteria are essential for chronic, immune-mediated
intestinal inflammation in a bacterial and host-specific manner. His clinical research investigates
antibiotics, probiotics and prebiotics in IBD.
Dr. Sartor has been one of the Best Doctors in America for the past 9 years. He has published over 250
peer-reviewed research articles, reviews, editorials and chapters and has edited 5 books, including Kirsner’s
Inflammatory Bowel Diseases, 6th edition with Bill Sandborn.
5